Cargando…

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma

Mitochondrial dysfunction is common in cancer, and the mitochondrial electron transport chain is often affected in carcinogenesis. So far, few is known about the expression of the mitochondrial complex III (ubiquinol-cytochrome c reductase complex) subunits in clear cell renal cell carcinoma (ccRCC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellinger, Jörg, Gromes, Arabella, Poss, Mirjam, Brüggemann, Maria, Schmidt, Doris, Ellinger, Nadja, Tolkach, Yuri, Dietrich, Dimo, Kristiansen, Glen, Müller, Stefan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349929/ https://www.ncbi.nlm.nih.gov/pubmed/27845902 http://dx.doi.org/10.18632/oncotarget.13275

Ejemplares similares

Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma
por: Brüggemann, Maria, et al.
Publicado: (2017)

Systematic expression analysis of m(6)A RNA methyltransferases in clear cell renal cell carcinoma
por: Gundert, Larissa, et al.
Publicado: (2021)

The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma
por: Cox, A., et al.
Publicado: (2020)

Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression
por: Bläsius, Felix Marius, et al.
Publicado: (2017)

Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
por: Stinnesbeck, Melissa, et al.
Publicado: (2021)

Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
por: Heinemann, Frauke G., et al.
Publicado: (2018)

LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
por: Syring, Isabella, et al.
Publicado: (2018)

Apelin and apelin receptor expression in renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2019)

YRNA expression predicts survival in bladder cancer patients
por: Tolkach, Yuri, et al.
Publicado: (2017)

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
por: Gevensleben, Heidrun, et al.
Publicado: (2016)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma
por: Simon, Adrian Georg, et al.
Publicado: (2022)

Identification of aberrant tRNA-halves expression patterns in clear cell renal cell carcinoma
por: Nientiedt, Malin, et al.
Publicado: (2016)

CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
por: Goltz, Diane, et al.
Publicado: (2016)

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
por: Holmes, Emily Eva, et al.
Publicado: (2016)

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma
por: Frey, Lisa, et al.
Publicado: (2021)

Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
por: Simon, Adrian Georg, et al.
Publicado: (2020)

Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling
por: Deng, Mario, et al.
Publicado: (2015)

Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
por: Blondeau, Jasmine JC, et al.
Publicado: (2015)

Inflammatory fibroid polyp of the renal pelvis: first report at an extra-gastrointestinal site with molecular confirmation
por: Nagy, Dora, et al.
Publicado: (2023)

CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2021)

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
por: Krausewitz, Philipp, et al.
Publicado: (2022)

Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysis
por: Kalogirou, Charis, et al.
Publicado: (2020)

Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
por: Esser, Laura K., et al.
Publicado: (2020)

Nutlin-3a Decreases Male Fertility via UQCRC2
por: Shukla, Kamla Kant, et al.
Publicado: (2013)

Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy
por: Lin, Chin-Hsien, et al.
Publicado: (2020)

Analysis of Tissue and Serum MicroRNA Expression in Patients with Upper Urinary Tract Urothelial Cancer
por: Kriebel, Stephanie, et al.
Publicado: (2015)

Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers
por: Kremer, Anika, et al.
Publicado: (2019)

Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression
por: Klümper, Niklas, et al.
Publicado: (2017)

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer
por: Tolkach, Yuri, et al.
Publicado: (2022)

Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer
por: Wang, Qing, et al.
Publicado: (2020)

UQCRC1 variants in early-onset and familial Parkinson's disease in a Taiwanese cohort
por: Liao, Ting-Wei, et al.
Publicado: (2022)

Tryptophan Oxidation in the UQCRC1 Subunit of Mitochondrial Complex III (Ubiquinol-Cytochrome C Reductase) in a Mouse Model of Myodegeneration Causes Large Structural Changes in the Complex: A Molecular Dynamics Simulation Study
por: Unni, Sruthi, et al.
Publicado: (2019)

N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma
por: Condic, Mateja, et al.
Publicado: (2022)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study
por: Krausewitz, Philipp, et al.
Publicado: (2022)

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
por: Kristiansen, Ilka, et al.
Publicado: (2017)

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jtvjjqft7smpm0cc6qta99cgim